Drug intelligence / Profile preview

RNArt

Development stage: Preclinical
Lead developer: RNArt
Modality: mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration: Intravenous, Intramuscular, Subcutaneous

Overview

RNArt is an early-stage biotechnology platform focused on the development of circular RNA (circRNA) therapeutics. Founded by pioneers in RNA biology, including Thomas Tuschl and Nikolaus Rajewsky, the platform leverages the unique structural properties of circular RNA to overcome the limitations of traditional linear mRNA, such as rapid degradation by exonucleases. By creating covalently closed loops, RNArt's technology aims to provide enhanced stability and prolonged protein expression in vivo. The platform is designed to enable the translation of therapeutic proteins over extended periods, potentially reducing the frequency of dosing compared to conventional mRNA therapies. RNArt's primary focus includes the development of next-generation RNA treatments for oncology, protein replacement therapies, and vaccines, utilizing specialized delivery systems to target specific tissues and organs.

Other names: RNArt circular RNA platform

Beyond the preview

Go deeper on RNArt.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNArt.

Explore the full profile